https://www.selleckchem.com/products/abt-199.html
gnitude of the differences depends on treatment deferability, patient sociodemographic subgroups, and facility characteristics.Importance The number of children with prenatal opioid exposure to medication for addiction treatment (MAT) with methadone and buprenorphine for maternal opioid use disorder is increasing, but the associations of this exposure with cognitive outcomes are not well understood. Objective To examine the strength and consistency of findings in the medical literature regarding the association of prenatal exposure to M
Me gusta
Comentario
Compartir
